BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Echeverría N, Comas V, Aldunate F, Perbolianachis P, Moreno P, Cristina J. In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet? . World J Hepatol 2021; 13(10): 1234-1268 [PMID: 34786164 DOI: 10.4254/wjh.v13.i10.1234]
URL: https://www.wjgnet.com/1948-5182/full/v13/i10/1234.htm
Number Citing Articles
1
Ashraf Elbahrawy, Hassan Atalla, Mohamed Alboraie, Ahmed Alwassief, Ali Madian, Mohammed El Fayoumie, Ashraf A. Tabll, Hussein H. Aly. Recent Advances in Protective Vaccines against Hepatitis Viruses: A Narrative ReviewViruses 2023; 15(1): 214 doi: 10.3390/v15010214
2
Amirhosein Faghihkhorasani, Hanan Hassan Ahmed, Noor Muhammad Mashool, Mariem Alwan, Marjan Assefi, Aya Hussein Adab, Saman Yasamineh, Omid Gholizadeh, Moein Baghani. The potential use of bacteria and bacterial derivatives as drug delivery systems for viral infectionVirology Journal 2023; 20(1) doi: 10.1186/s12985-023-02183-z
3
Noura M. Alshiban, Munirah S. Aleyiydi, Majed S. Nassar, Nada K. Alhumaid, Thamer A. Almangour, Yahya M.K. Tawfik, Laila A. Damiati, Abdulaziz S. Almutairi, Essam A. Tawfik. Epidemiologic and clinical updates on viral infections in Saudi ArabiaSaudi Pharmaceutical Journal 2024; 32(7): 102126 doi: 10.1016/j.jsps.2024.102126
4
Kainat Ahmed, Sudhakar Jha. Oncoviruses: How do they hijack their host and current treatment regimesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(5): 188960 doi: 10.1016/j.bbcan.2023.188960
5
Alia Alassad, Mhd Jawad Al Rahwanji, Amal Yousfan, Sally Al Moualem, Arwa Farhat, Lama A. Youssef. Seroprevalence and trends of hepatitis B virus, hepatitis C virus and human immunodeficiency virus in Syrian blood donors at Damascus University Blood Center between 2004 and 2021Frontiers in Public Health 2023; 11 doi: 10.3389/fpubh.2023.1174638
6
Victor Kupriyanov, Lyudmila Nikolaeva, Alexander Grishechkin, Evgeny Samokhvalov, Anna Dedova, Anna Zykova, Nikolai Ravin. Dendritic cells derived from induced pluripotent stem cells and stimulated by antigens of hepatitis C virus efficiently activate T-lymphocytesJournal of Biosciences 2024; 49(4) doi: 10.1007/s12038-024-00469-0
7
Ahmed A. Ali, Ashraf A. Tabll. Unlocking potential: Virus-like particles as a promising strategy for effective HCV vaccine developmentVirology 2025; 602: 110307 doi: 10.1016/j.virol.2024.110307
8
Rafid Jihad Albadr, Hayder Naji Sameer, Zainab H. Athab, Mohaned Adil, Ahmed Yaseen, Omer Qutaiba B. Allela. Recent Advances in mRNA-Based Vaccines Against Several Hepatitis VirusesBiological Procedures Online 2025; 27(1) doi: 10.1186/s12575-025-00269-2
9
Ashraf A. Tabll, Sayed S. Sohrab, Ahmed A. Ali, Ana Petrovic, Sabina Steiner Srdarevic, Stjepan Siber, Marija Glasnovic, Robert Smolic, Martina Smolic. Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus VaccinePathogens 2023; 13(1): 38 doi: 10.3390/pathogens13010038
10
A. Kouakou Viviane, Sevede Daouda, Doumbia Moussa, E. Assohoun Stanislas, Dosso Mireille. Evaluation of viral hepatitis C screening at Institut Pasteur of Cte dIvoire from 2012 to 2022African Journal of Biotechnology 2023; 22(11): 286 doi: 10.5897/AJB2023.17615
11
Laura Cardoso Corrêa-Dias, Ágata Lopes-Ribeiro, Geovane Marques-Ferreira, Letícia Gomes-de-Pontes, Thaiza Aline Pereira-Santos, Erik Vinicius de Sousa Reis, Thaís de Fátima Silva Moraes, Olindo Assis Martins-Filho, Edel Figueiredo Barbosa-Stancioli, Flávio Guimarães da Fonseca, Jordana Grazziela Coelho-dos-Reis. HCV immunodominant peptide mapping reveals unique HLA-A*02-restricted signatures: insights for CD8+ T-cell-based vaccines and immunotherapiesImmunogenetics 2025; 77(1) doi: 10.1007/s00251-025-01370-2